Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis
- PMID: 3894171
- PMCID: PMC1432788
- DOI: 10.1136/gut.26.8.822
Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis
Abstract
A double blind controlled trial has been conducted in 40 patients to compare the therapeutic effects of prednisolone metasulphobenzoate enemas with those of prednisolone-21-phosphate enemas. Both enemas brought about improvement in symptoms and sigmoidoscopic appearances in more than 70% of patients treated. The absorption of prednisolone from the metasulphobenzoate enema in three patients was less than from the 21-phosphate enema. In view of the low plasma prednisolone concentrations obtained, there are theoretical advantages in using a poorly absorbed enema to avoid the possibility of systemic steroid effects in patients requiring long term steroid treatment.
Similar articles
-
A comparison of prednisolone enemas with low-dose oral prednisolone in the treatment of acute distal ulcerative colitis.Dis Colon Rectum. 1984 Nov;27(11):701-2. doi: 10.1007/BF02554591. Dis Colon Rectum. 1984. PMID: 6499602 Clinical Trial.
-
A prospective randomized double blind trial comparing prednisolone and 4-aminosalicylic acid enemas in acute distal ulcerative colitis.J Gastroenterol Hepatol. 1992 Mar-Apr;7(2):173-7. doi: 10.1111/j.1440-1746.1992.tb00957.x. J Gastroenterol Hepatol. 1992. PMID: 1571500 Clinical Trial.
-
A comparison of sucralfate and prednisolone enemas in the treatment of active distal ulcerative colitis.Scand J Gastroenterol. 1989 Oct;24(8):1014-8. doi: 10.3109/00365528909089249. Scand J Gastroenterol. 1989. PMID: 2688065 Clinical Trial.
-
Treatment of distal ulcerative colitis with nonsystemic corticosteroid enemas.Scand J Gastroenterol. 1996 Oct;31(10):945-53. doi: 10.3109/00365529609003112. Scand J Gastroenterol. 1996. PMID: 8898413 Review. No abstract available.
-
Short-chain fatty acid enemas in the treatment of distal ulcerative colitis.Eur J Gastroenterol Hepatol. 1997 Feb;9(2):149-53. doi: 10.1097/00042737-199702000-00008. Eur J Gastroenterol Hepatol. 1997. PMID: 9058625 Review. No abstract available.
Cited by
-
Drug management of ulcerative colitis.BMJ. 1992 Jul 4;305(6844):35-8. doi: 10.1136/bmj.305.6844.35. BMJ. 1992. PMID: 1638200 Free PMC article. Review. No abstract available.
-
Clinical pharmacokinetics of prednisone and prednisolone.Clin Pharmacokinet. 1990 Aug;19(2):126-46. doi: 10.2165/00003088-199019020-00003. Clin Pharmacokinet. 1990. PMID: 2199128 Review.
-
Optimization of conventional therapy in patients with IBD.Nat Rev Gastroenterol Hepatol. 2011 Oct 4;8(11):646-56. doi: 10.1038/nrgastro.2011.172. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21970871 Review.
-
Drug therapy of ulcerative colitis.Br J Clin Pharmacol. 1992 Sep;34(3):189-98. doi: 10.1111/j.1365-2125.1992.tb04124.x. Br J Clin Pharmacol. 1992. PMID: 1389944 Free PMC article. Review. No abstract available.
-
A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis.Gut. 1996 Feb;38(2):229-33. doi: 10.1136/gut.38.2.229. Gut. 1996. PMID: 8801202 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical